InvestorsHub Logo
Followers 14
Posts 968
Boards Moderated 0
Alias Born 04/27/2012

Re: nferna post# 15593

Tuesday, 07/26/2022 10:05:55 PM

Tuesday, July 26, 2022 10:05:55 PM

Post# of 17441
If it was that obvious, why did the USPTO grant the patent?

“Patent No. 10,286,036 was issued to Aurinia in support of the unique eGFR pharmacodynamic dosing protocol used within the Company’s clinical”

Need to look at the claims in the patent. Anybody here familiar with eGFR monitoring methods?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News